NCT06941298 (Cann-Teen) is a NA clinical trial of Neuroimaging Investigation in Cannabis Use, sponsored by University of Miami.

Who is sponsoring NCT06941298?

NCT06941298 is sponsored by University of Miami.

What drugs are being tested in NCT06941298?

Interventions in NCT06941298: Neuroimaging Investigation.

What condition does NCT06941298 study?

NCT06941298 studies Cannabis Use, Depression.

Is NCT06941298 still recruiting?

NCT06941298 is currently recruiting now. Last updated 23 April 2025.

Last reviewed 2025-04-23 · How we verify

NCT06941298: Cann-Teen

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neural and Psychiatric Consequences of Cannabis Use in Adolescents

Recruiting now NA Last updated 23 April 2025

What this trial tests

NA trial testing Neuroimaging Investigation in Cannabis Use in 280 participants. Currently enrolling.

Timeline

4 March 2025

Primary endpoint
1 June 2029

1 June 2029

Quick facts

Lead sponsor	University of Miami
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	280
Start date	4 March 2025
Primary completion	1 June 2029
Estimated completion	1 June 2029
Sites	2 locations across United States

Drugs / interventions tested

Neuroimaging Investigation

Conditions studied

Cannabis Use — all drugs for Cannabis Use →
Depression — all drugs for Depression →

Sponsor

University of Miami

Who can join

Adults 14 to 20, any sex, with Cannabis Use or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to investigate the effects of cannabis on brain function among adolescents with depression.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cannabis Use

Currently open trials in the same condition.

NCT07196462 — Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia · NA · recruiting
NCT07168707 — Culturally Adapted EAET-H for Chronic Pain Patients Using Medical Cannabis in Israel - A Pilot Study · NA · recruiting
NCT05999383 — Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration · Phase 2 · recruiting
NCT06883162 — Cannabis-Tobacco Co-Use Treatment Study · Phase 3 · recruiting
NCT06699251 — Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat) · NA · recruiting

Other University of Miami trials

Trials by the same sponsor.

NCT06003712 — Exploring the Effect of Mindfulness on Quality of Life (QoL) in Spinal Cord Injury (SCI) · NA · not yet recruiting
NCT06077071 — MRIdian "RADAR" Trial · NA · not yet recruiting
NCT07472413 — Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project · Phase 3 · not yet recruiting
NCT07322289 — Antibiotic-coated Braided Suture Study · NA · not yet recruiting
NCT07469592 — eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06941298 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Miami
Last refreshed: 23 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06941298.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing